In the present study, the binding potential (BP) of the D 2 receptor radioligand [
INTRODUCTION
During the last decade, small animal positron emission tomography (PET) increasingly has been employed for the investigation of dopamine D 2 receptor binding in rat models of senescence, drug abuse, depression, attention-deficit hyperactivity disorder and neurodegenerative diseases including M. Parkinson and M. Huntington (for review see [1, 2] ).
In PET investigations on humans, binding data are commonly analyzed applying the direct kinetic approach (for review see [3] ). A prerequisite for this method is the measurement of the arterial free ligand concentration. Arterial input functions, however, are difficult to obtain in investigations performed on rat or mouse models, as sufficient amounts of blood may not repeatedly be drawn from animals of this small size. Moreover, the configuration as such of dedicated small animal PET scanners of the first generation (e.g. TierPET, RATPET, MADPET) precludes the kinetic modeling of data, as the initial radioligand uptake may not be measured with a sufficient temporal resolution. Typically, these scanners have a comparatively low *Address correspondence to this author at the Clinic of Nuclear Medicine, University Hospital Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany; Tel: 0049-(0)211-81-17048; Fax: 0049-(0)211-81-17041; E-mail: Susanne.Nikolaus@uni-duesseldorf.de sensitivity (10 to 40 cps/kBq; for review see [4] ), which makes them merely suitable for a quasi-dynamic acquisition of data. Apart from limitations due to the scanner characteristics, PET investigations may be confounded by varying and low specific activities of the radiotracers possibly leading to the saturation of receptor binding. As a consequence, investigators must meet the challenge to elaborate reasonable compromises between the desirable and the feasible in small animal imaging.
In the small animal PET studies performed until now, the need for an arterial input function was obviated either by confinement to expressing radioactivity values as percentage of the injected dose per tissue volume [5] , or by applying dynamic [6] [7] [8] , non-invasive graphic [9] [10] [11] [12] [13] , and simplified reference tissue models [12, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . We recently proposed the performance of in vivo saturation binding analysis of [ 18 F]N-methyl-benperidol ([ 18 F]FMB) binding to the D 2 receptors in the rat striatum [24] [25] [26] . One benefit of the saturation binding approach is that it allows the separate determination of receptor density (B max ) and the dissociation constant (K d ) as a measure of affinity. Moreover, this method per definition requires the saturation of receptor binding and, thus, the application of increasing radioligand concentrations. As a consequence, radiochemical syntheses delivering radioligands with low specific activities must not be discarded, but may even be used to advantage, when in vivo saturation binding analysis can be applied. For the purpose of validation, in the present study, BP additionally was determined in the same animals by computing the equilibrium ratio of the distribution volumes of the specifically and the non-specifically bound compartment (V 3 ''= V 3 /V 2 ) as an estimate for BP [27] . V 3 '' can be obtained as (V T /V 2 ) -1, with V T denoting the total tissue equilibrium volume of distribution, equal to the sum of V 2 and V 3 . If it is assumed that the equilibrium concentrations of free and non-specifically bound ligand are the same across brain regions, V 2 may be inferred from a reference region (REF) devoid of the target receptor (e.g. cortex or cerebellum), and V 3 '' in the striatum is obtained as
In all small animal PET and SPECT investigations using cerebral reference tissue for the quantification of specific D2 receptor radioligand binding, the cerebellum has been employed as a REF (for review see [1] ). Matters, however, are different in clinical investigations of D 2 receptor binding, where cerebellar (e.g. [28] [29] [30] ) and cortical REFs (e.g. [31] [32] [33] ), have been used to the same extent. Autoradiographic studies on cerebral tissues of rats have shown that frontocortical and cerebellar D 2 receptor ligand accumulations amounted to 3 and 1%, respectively, of striatal binding [34] . Similarly, in humans, frontocortical and cerebellar D 2 receptor ligand accumulations fell short of striatal binding by 90 and a 98%, respectively [31] .
These differences prompted us to additionally assess the influence of the chosen reference tissue on the BP of [
18 F]FMB in the rat striatum obtained with either in vivo saturation binding analysis and the equilibrium distribution volume method.
MATERIALS AND METHODOLOGY

Animals
Eight male Sprague-Dawley rats (Charles River, France), weighing between 300 and 500 g were investigated with small animal PET. The study was approved by the regional authority; it was carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23, rev. 1996 and and the German Law on the Protection of Animals.
Radiochemistry
[
18 F]FMB was synthesized as previously described [35] . Nucleophilic aromatic fluorination via 18 F-for-nitroexchange was performed according to the method described for the butyrophenone ligand [ 18 F](N-methyl)-spiperone [36] . The radiochemical purity was above 98% as determined with High Performance Liquid Chromatography. [ 18 F]FMB is rapidly metabolized in the periphery [37] . Thereby, chromatographic analysis suggests that only polar metabolites are formed, which do not partition into the brain [38] . Specific activity at injection time covered one order of magnitude (range: > 11 to > 100 TBq/mmol). The molar amounts of injected radioligand ranged from 0.81 to 0.54 nmol.
Acquisition of Imaging Data
Instrumentation. The small animal tomograph ("TierPET", Zentrallabor für Elektronik', Forschungszentrum Jülich GmbH, Jülich, Germany) was described in detail elsewhere [39] . Axial as well as transaxial field of view had a diameter of 40 mm. The resolution amounted to 2.1 mm (FWHM). One count/sec/mm as registered with the camera corresponded to 444 Bq/mm [40] ; this value served as a calibration factor in order to calculate radioactivity concentrations from the count rates within the ROIs.
Protocol. After short-time inhalation anesthesia with isofluran, animals received intramuscular injections of ketamine (concentration: 100 mg/ml, dose: 0.9 ml/kg) and xylazine (concentration: 0.02 mg/ml, dose: 0.4 ml/kg). [ 18 F]FMB (70.4 ± 8.7 MBq; mean ± SD) was diluted in 0.9% saline containing 10% ethanol and injected into the right jugular vein. The mean injection volume was 1 ± 0.5 ml; the mean injected radioactivity dose amounted to 158.3 ± 24.2 MBq/kg.
Time-activity curves had shown that the equilibrium between radioactivity concentrations of specifically-bound and both non-specifically bound and free [
18 F]FMB is reached at 20 min post-injection and remains stable for up to 3 hours [41] . In the present study, imaging data were acquired dynamically for 36 min (6 time frames of 6 min each) with angular steps of 7.5° (30 sec per angular step). The mean delay between application of the radioligand and start of the measurement amounted to 8.1 ± 4.4 min. The data processing was described in detail elsewhere [25, 26, 41] . Image reconstruction was performed in consecutive slices of 2 mm thickness.
Evaluation
Saturation binding analysis. Images were analyzed with the Multi Purpose Imaging Tool (version 2.57; Advanced Tomo Vision, Erftstadt, Germany). According to the standard rat brain atlas by Paxinos and Watson [42] , striata and cerebellum were localized individually for each animal on coronal sections. Two standard circular ROIs with diameters of 2.5 mm were drawn around the centers of both striata. Within the cerebellum, a circular region with a diameter of 5.5 mm was delineated. The positions but not the sizes of the ROIs were adjusted individually for each animal by two operators, independently. The obtained radioactivity values were corrected for radioactive decay. As time-activity curves had shown that the equilibrium between radioactivity concentrations of specifically-bound and both nonspecifically bound and free [ 18 F]FMB was reached at 20 min post-injection, left and right radioactivity concentrations in time frames four to six were averaged according to the latetime method [43] .
Previous investigations with the TierPET had shown that in a target with a diameter of 2.5 mm, radioactivity was underestimated by approximately 60% [40] . On the basis of these measurements partial volume corrections were perfomed for the striatum of each side. After decomposition of the sum function into a glandular, striatal and cortical portion, the amount of spill-over was determined by relating the integrals of the overlaps to the integrals of the curves (Fig. 1B) . The percentual contributions of one curve to another were subtracted for each side from the striatal radioactivity concentrations.
Either cortical radioactivity -as inferred from the lineactivty profiles -or cerebellar radioactivity was considered as an estimate of the free and non-specifically bound radioligand in brain tissue. From striatal, cortical and cerebellar radioactivity concentrations (MBq/mm ) and the known specific activity at the beginning of the fourth time frame, striatal, cortical and cerebellar molar radioligand concentrations (fmol/mg) were calculated. For each animal, either cortical or cerebellar molar concentrations were subtracted from left and right striatal radioligand concentrations in order to obtain specific binding. For left and right striatum specific binding was averaged. The results obtained with cortical radioactivity as an estimate of the free and non-specifically bound radioligand have been previously published [24] .
For non-linear regression analysis (GraphPad Prism, GraphPad Software, San Diego, USA), saturation binding ) between striatal and orbital curve was taken as a measure for spill-over. Cortical radioactivity (3) was used to estimate free and non-specific binding. For each animal, the mean cortical values are subtracted from striatal radioactivity concentrations as averaged over time frames four to six. (C) For the analysis of data according to the equilibrium distribution volume method, standard circular ROIs with diameters of 2.5 mm and 1.2 mm, respectively, were drawn around the centers of both striata and within the adjacent cortex of each side. Within the cerebellum, a region with a diameter of 5.5 mm was defined. Equilibrium distribution volume method. After summation of time frames 4 to 6, standard circular ROIs with diameters of 2.5 mm and 1.2 mm, respectively, were drawn around the centers of both striata and within the adjacent parietooccipital cortex of each side. Within the cerebellum, a circular region with a diameter of 5.5 mm was delineated (Fig. 1C) . Left and right striatal as well as cortical count rates were averaged. Partial-volume effects led to an underestimation of striatal radioactivity by approximately 60%, while spill-over determined as described above caused an overestimation by 5%; striatal count rates were corrected on the basis of these values [40] . For each animal, V 3 '' was computed by dividing radioactivity counts in the ROI (striatum, parietooccipital cortex) by radioactivity counts in the REF (parietooccipitalcortex and cerebellum, respectively) and subtracting 1. The V 3 '' values obtained for each animal were averaged, and standard deviations of the means (SD) were computed. Striatal V 3 '' values obtained with either cortical or cerebellar reference tissue and striatal and cortical V 3 '' values were compared using the paired ttest ( = 0.05).
RESULTS
Decay corrected striatal radioactivity concentrations amounted to 30 ± 6 counts/pixel (mean ± SD) corresponding to 0.14 ± 0.04 MBq/cm . After corrections for partial volume effect and spill-over, striatal count rates and radioactivity concentrations were 74 ± 14 counts/pixel and 0. 35 Fig. 2A) Equilibrium distribution volume method. V 3 '' obtained with cortical and cerebellar reference tissue amounted to 2.2 ± 0.3 and 3.2 ± 0.6, respectively (paired t-test, p two-tailed < 0.0001). For the cortex, a V 3 '' of 0.29 ± 0.1 was obtained. V 3 '' values differed significantly between cortex and striatum (paired t-test, p two-tailed < 0.0001; data not shown). [34] .
DISCUSSION
For in vivo saturation binding analyses with the concentration parameters derived from cortical and cerebellar radioactivity concentrations R values of 0.8 and 0.7, respectively, were obtained, indicating in either case a reasonable goodness of fit of non-linear regression analysis. In contrast, with r values of 0.4 and 0.1, respectively, the goodness of fit of linear regression analysis was poor. The %CV's for K d and B max values obtained with the concentration parameter derived from the cerebellum were higher (70% and 36%, respectively) than for K d and B max values obtained with the concentration parameter derived from the cortex (61% and 30%, respectively). This as well as the slightly higher R value obtained for in vivo saturation binding analysis with a cortical concentration parameter implies that our method of estimating cortical radioactivity concentrations from Gaussian fits to line-activity profiles may be less prone to errors than the delineation of cerebellar reference regions without concurrent morphological imaging.
Interestingly, nonwithstanding the statistically significant differences between binding values obtained with cortical or cerebellar reference tissue, results obtained with both in vivo saturation binding analysis and equilibrium distribution volume method are in the same order of magnitude as previous ex vivo findings of Suehiro et al., who assessed 11 C(N-methyl)benperidol binding in mice and reported striatum to cerebellum and cortex to cerebellum ratios of 6.2 and 1.2 corresponding to V 3 '' values of 5.2 and 0.2, respectively [44] . Similarly, in vivo measurements of [ 18 F]FMB binding in baboons yielded a striatum to cerebellum ratio of 4 at 35 min post-injection [41] . In comparing in vivo and in vitro measurements, however, various issues should be considered: firstly, the exact determination of the anterioposterior stereotaxic coordinates of the PET slices is hampered, when no concurrent morphological imaging may be performed, as was the case in our investigation. Non-corresponding sectional planes between PET and autoradiography, thus, offer one explanation for the difference between receptor densities obtained in vivo and in vitro. Secondly, the applied partial-volume correction factor was estimated on the basis of phantom studies, and entered as a constant factor into the quantification of radioactivity values irrespective of the actual striatal diameters on the slices selected for ROI definition. If the striatal diameter had fallen below 2.5 mm, the used correction factor would have led to an underestimation of radioactivity concentration compared to autoradiography. This may have been the case, since the selection of slices was performed not only with respect to the localization of the striatal activity maxima but also with the intent to minimize spill-over form the adjacent retroorbital tissue. Thirdly, in vivo and in vitro, the mean free ligand concentration in tissue is assumed to be equal to the 'true' free ligand concentration in the vicinity of the binding sites. We do not know to which extent this assumption is violated in either case. In vitro, the 'true' free radioligand concentration may be influenced by the diffusion of molecules into the brain tissue, which -apart from external conditions such as temperature -in turn depends on the degree of cellular destruction in the cryosections. Moreover, in the in vitro experiment [24] , no non-specifically bound portions of [ 18 F]FMB were present in the radioligand solution, and the free radioligand concentration as such entered into the saturation binding analysis possibly leading to an overestimation of specific binding.
In the in vivo saturation binding approach, accuracy depends on the correctness of the assumption that C 2 and C 2 ' may be pooled into one compartment. Actually, we derive [L] , that is, both the free and the non-specifically bound radioligand concentration from either the cortical or the cerebellar tissue. Thus, in our approach, BP is given by [ [45] . A REF is used for the estimation of C 2 + C 2 ', and also here the portion of nonspecifically bound radioligand may lead to underestimations of BP. As in the equilibrium distribution volume method, f 2 B max /K d is obtained as an outcome measure.
In discussing possible errors of parameter estimation, their degree, however, should be viewed in relation to other error sources inherent to the method of in vivo PET imaging, such as spill-over and partial-volume effect. For the nonspecific binding, moreover, holds that it is characterized by both tissue and radioligand properties, which are not assumed to vary over time or between subjects. Thus, f 2 B max and K d , as well as f 2 B max /K D , obtained with in vivo saturation binding analysis and simplified reference tissue model and equilibrium distribution volume method, respectively, can be considered to provide reasonable estimates of the receptor parameters in question. Thereby, the particular advantage of in vivo saturation binding analysis is the provision of B max (') and K d as separate values and direct measures of receptor density and affinity.
Taken together, findings show that for the quantitation of D 2 receptor binding in the rat striatum in vivo saturation binding analysis may be used as well as the equilibrium distribution volume method. Moreover, both cortexespecially the parietooccipital cortex, which was used in the present investigation -and cerebellum may be suitable as reference tissue with respect to striatal D 2 receptor binding. As to in vivo saturation binding analysis, both regions are likely to provide reasonable estimates of free and nonspecific radioligand concentrations. However, the significant difference between binding values obtained with cortical and cerebellar tissues indicates that caution should be exerted in choosing the reference tissue with regard to the intended investigation. The cortex may be adequate in intra-or interindividual comparisons between varying experimental conditions. One example is the multiple investigation of the same animals in order to assess 6-hydroxydopamine-induced changes of D 2 receptor binding [25] . It is advisable, however, to select a region devoid of D 2 receptors such as the cerebellum, if the in vivo characterization of a novel D 2 receptor ligand is intended, which requires a more accurate quantification of the BP.
Thereby, it should be born in mind, that in our investigation, in vivo saturation binding analysis obtained with the concentration parameter obtained from cortical radioactivity was more robust compared to in vivo saturation binding analysis with cerebellar radioactivity as an estimate of free and non-specific binding, with the confinement, however, that this might have been due to our method of deriving cortical radioactivity from Gaussian fits to lineactivity profiles placed through Harderian glands, striatum and adjacent cortical tissue. This method was chosen, as it permitted to account for spill-over between the individual regions. In small animal investigation performed with higher resolving PET cameras analysis of line-activity profiles, probably, can be dispensed with. In addition, coregistration with CT images, which is state of the art now, will render possible a more exact definition of ROIs and REFs improving the exactitude of parameter estimation with both (non-linear) regression analysis of saturation binding curves and the equilibrium distribution volume method.
